Back to search

Zentiva Pharma UK Ltd

31 contracts won£7,608,499,973 total value

Every public sector contract Zentiva Pharma UK Ltd has won, with the buyer, value and end date for each. When these contracts approach their end date they usually return to the market. Business predicts when, follows Zentiva Pharma UK Ltd for you, and alerts you the moment a renewal goes live.

Where they win

The sectors, tender types and buyers where Zentiva Pharma UK Ltd wins most often.

See every live NHS tenders and find your next contract before they do.

See all NHS buyers and UK contract awards.

Sectors

Healthcare & Medical31

Top Buyers

NHS England
20 contracts
£6,850,156,221
The NHS Commissioning Board (operating under the name of NHS England)
3 contracts
NHS england
2 contracts
£84,614,802
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
1 contract
£13,534,493
The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
1 contract
£1,611,385
The Common Services Agency (more commonly known as Public Services Delivery Scotland (PSDS)
1 contract
£348,152
Regional Business Services Organisation, Procurement and Logistics Service
1 contract
£7,936
NHSE&I
1 contract
£230,000,000

Awards(31)

Sort:

Contraceptive Medicines

The Common Services Agency (more commonly known as Public Services Delivery Scotland (PSDS)
Scotland
£348,152
Awarded 6 Jul 2026

Generic, Branded Generic & Proprietary Medicinal Products - Group 18

Regional Business Services Organisation, Procurement and Logistics Service
Belfast
£7,936
Awarded 23 Jun 2026

NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025

NHS England
Runcorn
£986,282,758
Awarded 1 Jul 2025
Ends 31 Aug 2027

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender

NHS England
Runcorn
£1,241,520,444
Awarded 24 Mar 2025
Ends 30 Apr 2029

CM/TNS/24/5719 - NHS National Framework for the supply of Pomalidomide

NHS England
Runcorn, Cheshire
£17,087,000
Awarded 20 Feb 2025
Ends 31 May 2026

CM/TNS/24/5713 - NHS Framework for Transition products - 1 February 2025

NHS England
Runcorn, Cheshire
£9,867,000
Awarded 14 Jan 2025
Ends 31 May 2026

NHS National Framework for Transition products commencing 1 October 2024

NHS England
Runcorn, Cheshire
£16,224,000
Awarded 30 Sept 2024
Ends 31 May 2026

NHS Branded Medicines Tranche Framework for London and South of England

NHS England
Runcorn
£380,950,720
Awarded 22 Jul 2024
Ends 31 Aug 2026

NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024

NHS England
Runcorn
£1,009,500,000
Awarded 5 Apr 2024
Ends 30 Apr 2028

NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

NHS England
Runcorn
£688,010,000
Awarded 26 Jan 2024
Ends 31 Aug 2026

NHS South of England Branded Medicines - Tranche A - September 2023

NHS England
Runcorn
£249,832,000
Awarded 18 Jul 2023
Ends 31 Aug 2025

NHS London Branded Medicines - Tranche B - September 2023

NHS England
Runcorn
£231,083,000
Awarded 14 Jul 2023
Ends 31 Aug 2025

NHS National Generic Pharmaceuticals Wave 14b

Atamis LTD
Runcorn
£428,226,984
Awarded 7 Jul 2023
Ends 30 Sept 2025

NHS National Generics Pharmaceuticals Transition 2023_1

NHS england
Runcorn
£57,604,995
Awarded 5 May 2023
Ends 31 Jan 2025

NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals

NHS England
Runcorn
£304,504,000
Awarded 24 Apr 2023
Ends 30 Apr 2025

NHS National Generics Pharmaceuticals - Dasatinib and Paliperidone Injection

NHS england
Runcorn
£27,009,807
Awarded 28 Mar 2023
Ends 31 Jan 2025

NHS National Pharmaceuticals Dasatinib and Paliperidone Injection

NHS England
Leeds
Not specified
Awarded 21 Feb 2023
Ends 31 Jan 2025

NHS Midland & East Branded Medicines, Tranche B & Annual Tranche

NHS England
Runcorn
£480,429,000
Awarded 13 Feb 2023
Ends 28 Feb 2025

NHS Framework for North of England Branded Medicines Tranche A & Annual Tranche

NHS England
RUNCORN
£261,970,000
Awarded 8 Feb 2023
Ends 28 Feb 2025

NHS National Generic Pharmaceuticals Wave 14a

NHS England
East Midlands
£207,982,407
Awarded 14 Dec 2022
Ends 31 Jan 2025

Know when Zentiva Pharma UK Ltd's contracts come up for renewal

Business predicts when each of these contracts is due to be re-tendered, follows Zentiva Pharma UK Ltd for you, and alerts you the moment a renewal goes live, so you can bid before the incumbent locks it in again.

Page 1 of 2

Why track Zentiva Pharma UK Ltd?

Zentiva Pharma UK Ltd is an active supplier to UK public sector buyers. Their contract history is one of the clearest guides to where the work is: which authorities they serve, what those contracts are worth, and, most usefully, when each contract is due to end. A contract nearing its end date is an opportunity, because the buyer will usually run the work again.

How renewal tracking works

We aggregate Zentiva Pharma UK Ltd's award notices from 600+ UK and Irish sources and read the end date on each contract. From those dates, Business predicts when each contract is likely to be re-tendered and, if you follow the supplier, alerts you the moment a matching tender goes live. That head start lets you speak to the buyer and prepare a bid before the incumbent is confirmed again.

What you can do here

  • Review the full history. Every contract Zentiva Pharma UK Ltd has won, with the buyer, value and dates for each.
  • Spot upcoming renewals. Contracts approaching their end date are the ones most likely to reopen.
  • Track and get alerted. Follow Zentiva Pharma UK Ltd and be notified when their contracts come up again (Business).
  • Benchmark and target. See which buyers rely on them and at what value, then focus where you can win.

Frequently asked questions

Where does this data come from?

Official UK and Irish contract award notices, aggregated from 600+ sources and updated daily.

Is the contract history free?

Yes. The full award history, values and buyers are free to browse. Predicted renewal dates, following a supplier and renewal alerts are part of our Business plans.

How do you predict renewals?

From the end dates and durations recorded on awarded contracts. A contract at or near its end date is a strong candidate to return to the market.